Japan in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

Product Code GMD09570
Publication Date April 2009
Publisher Global Markets Direct
Product Type Report
Pages 177
ISBN Number not applicable
Change currency
PDF £1,580.00 €1,903 $2,498 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Japan in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

This report is an essential source for in-depth information and data relating to the Japan In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Japan

Scope

  • The report provides in vitro diagnostics information broken down into detailed categories and segments in Japan.
  • Total revenues, end users
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the in vitro diagnostics devices market in Japan.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 In Vitro Diagnostics
    • 3.2 Clinical Chemistry Test Reagents
    • 3.3 Immunochemistry Test Reagents
    • 3.4 Blood Test Reagents
    • 3.5 Microbiology Test Reagents
    • 3.6 Infectious Immunology Test Reagents
    • 3.7 Genetic Test Reagents
    • 3.8 Self Testing
    • 3.9 Instruments
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
  • 6 Pricing and Reimbursement
    • 6.1 Market Pricing
    • 6.2 Reimbursement Policies
    • 6.3 Reimbursement Classes
    • 6.4 Request for Reimbursement
    • 6.5 Reduction in Reimbursement for Medical Devices and Drugs
  • 7 Distribution Structure
  • 8 In Vitro Diagnostics In Japan
    • 8.1 In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015
    • 8.3 In Vitro Diagnostics, Japan, Company Share (2006-2007)
  • 9 Blood Test Reagents In Japan
    • 9.1 Blood Test Reagents Overall Revenue (2000-2015)
    • 9.2 Blood Test Reagents Distribution Share (2007-2008)
    • 9.3 Blood Test Reagents, Japan, Company Share (2006-2007)
  • 10 Clinical Chemistry Test Reagents In Japan
    • 10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2015)
    • 10.2 Clinical Chemistry Test Reagents Distribution Share (2007-2008)
    • 10.3 Clinical Chemistry Test Reagents, Japan, Company Share (2006-2007)
  • 11 Genetic Test Reagents In Japan
    • 11.1 Genetic Test Reagents Overall Revenue (2000-2015)
    • 11.2 Genetic Test Reagents Distribution Share (2007-2008)
    • 11.3 Genetic Test Reagents, Japan, Company Share (2006-2007)
  • 12 Immunochemistry Test Reagents In Japan
    • 12.1 Immunochemistry Test Reagents Overall Revenue (2000-2015)
    • 12.2 Immunochemistry Test Reagents Distribution Share (2007-2008)
    • 12.3 Immunochemistry Test Reagents, Japan, Company Share (2006-2007)
  • 13 Infectious Immunology Test Reagents In Japan
    • 13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2015)
    • 13.2 Infectious Immunology Test Reagents Distribution Share (2007-2008)
    • 13.3 Infectious Immunology Test Reagents, Japan, Company Share (2006-2007)
  • 14 Instruments In Japan
    • 14.1 Instruments Overall Revenue (2000-2015)
    • 14.2 Instruments Distribution Share (2007-2008)
    • 14.3 Instruments, Japan, Company Share (2006-2007)
  • 15 Microbiology Test Reagents In Japan
    • 15.1 Microbiology Test Reagents Overall Revenue (2000-2015)
    • 15.2 Microbiology Test Reagents Distribution Share (2007-2008)
    • 15.3 Microbiology Test Reagents, Japan, Company Share (2006-2007)
  • 16 Self Testing In Japan
    • 16.1 Self Testing Overall Revenue (2000-2015)
    • 16.2 Self Testing Distribution Share (2007-2008)
    • 16.3 Self Testing, Japan, Company Share (2006-2007)
  • 17 Overview of Key Companies in Japan In Vitro Diagnostics Market
    • 17.1 F. Hoffmann-La Roche Ltd
    • 17.2 Abbott Laboratories
    • 17.3 Beckman Coulter, Inc
    • 17.4 Dade Behring Holdings, Inc
    • 17.5 Siemens Healthcare
    • 17.6 Abbott Laboratories
    • 17.7 Siemens Healthcare
    • 17.8 Becton, Dickinson and Company
    • 17.9 Gen-Probe Incorporated
    • 17.10 bioMerieux S.A
    • 17.11 Genzyme Corporation
    • 17.12 OLYMPUS CORPORATION
    • 17.13 Ventana Medical Systems, Inc
    • 17.14 Digene Corporation
    • 17.15 ARKRAY, Inc
    • 17.16 Atto Corporation
    • 17.17 Biomaster, Inc
    • 17.18 BioOne Corporation
    • 17.19 Cosmo Bio Co., Ltd
    • 17.20 Eiken Chemical Co.,Ltd
    • 17.21 HORIBA, Ltd
    • 17.22 KYOWA HAKKO KOGYO Co., Ltd
    • 17.23 Nihon Kohden Corporation
    • 17.24 Otsuka Pharmaceutical Co., Ltd
    • 17.25 SEIKAGAKU CORPORATION
    • 17.26 Shionogi & Co., Ltd
    • 17.27 Sysmex Corporation
    • 17.28 Techno Medica Co., Ltd
    • 17.29 Tosoh Corporation
  • 18 Financial Deals Landscape
    • 18.1 Acquisition
  • 19 Recent Developments
    • 19.1 Product News
    • 19.2 Other Significant Developments
  • 20 Appendix
    • 20.1 Global Markets Direct Research Methodology
    • 20.2 Coverage
    • 20.3 Secondary Research
    • 20.4 Primary Research
    • 20.5 Models
    • 20.6 Forecasts
    • 20.7 Expert Panel Validation
    • 20.8 Currency Conversion
    • 20.9 Contact Us
    • 20.10 Disclaimer
  • 1 List of Tables
    • Table 1: Healthcare Expenditure in Japan, 2000 - 2005
    • Table 2: Number of Healthcare Institutions in Japan, 1995 2004
    • Table 3: Number of Hospital Beds in Japan, 1995 2004
    • Table 4: Number of Medical Personnel in Japan, 1995 - 2004
    • Table 5: Number of Doctors by Specialty in Japan, 2003-2007
    • Table 6: Number of Medical Care Institutions and Beds in Japan, 2000 - 2004
    • Table 7: Registration Processing Time for Medical Devices in Japan, 2007
    • Table 8: Product Registration Fee for Medical Devices in Japan, 2007
    • Table 9: In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 10: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015
    • Table 11: In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-2015
    • Table 12: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 13: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 14: In Vitro Diagnostics, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 15: Blood Test Reagents, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 16: Blood Test Reagents, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 17: Haematology Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 18: Haematology Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 19: Hemostasis Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 20: Hemostasis Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 21: Blood Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 22: Blood Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 23: Clinical Chemistry Test Reagents, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 24: Clinical Chemistry Test Reagents, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 25: Clinical Chemistry Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 26: Clinical Chemistry Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 27: Genetic Test Reagents, Japan, Revenue ($ mn), Historic, 2000-2008
    • Table 28: Genetic Test Reagents, Japan, Revenue ($ mn), Forecast, 2008-2015
    • Table 29: Genetic Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 30: Genetic Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 31: Immunochemistry Test Reagents, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 32: Immunochemistry Test Reagents, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 33: Disease Specific Markers, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 34: Disease Specific Markers, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 35: Disease Specific Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 36: Disease Specific Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 37: Drug Related Testing Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 38: Drug Related Testing Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 39: Hormone Related Testing Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 40: Hormone Related Testing Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 41: Immunochemistry Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 42: Immunochemistry Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 43: Infectious Immunology Test Reagents, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 44: Infectious Immunology Test Reagents, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 45: Virology, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 46: Virology, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 47: Infectious Immunology Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 48: Infectious Immunology Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 49: Instruments, Japan, Revenue ($ mn), Historic, 2000-2008
    • Table 50: Instruments, Japan, Revenue ($ mn), Forecast, 2008-2015
    • Table 51: Instruments, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 52: Instruments, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 53: Microbiology Test Reagents, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 54: Microbiology Test Reagents, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 55: Bacteriology Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 56: Bacteriology Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 57: Microbiology Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 58: Microbiology Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 59: Self Testing, Japan, Revenue ($ mn), Historic, 2000-2008
    • Table 60: Self Testing, Japan, Revenue ($ mn), Forecast, 2008-2015
    • Table 61: Self Testing, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 62: Self Testing, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 63: Beckman Coulter, Inc. Pipeline Products by Equipment Type
    • Table 64: Beckman Coulter, Inc. Pipeline Products By Development Stage
    • Table 65: Beckman Coulter, Inc. Pipeline Products By Therapy Area
    • Table 66: Beckman Coulter, Inc. Pipeline Products By News Summary
    • Table 67: Gen-Probe Incorporated Pipeline Products by Equipment Type
    • Table 68: Gen-Probe Incorporated Pipeline Products By Development Stage
    • Table 69: Gen-Probe Incorporated Pipeline Products By Therapy Area
    • Table 70: Gen-Probe Incorporated Pipeline Products By Clinical Trials
    • Table 71: Gen-Probe Incorporated Pipeline Products By News Summary
    • Table 72: Genzyme Corporation Pipeline Products by Equipment Type
    • Table 73: Genzyme Corporation Pipeline Products By Development Stage
    • Table 74: Genzyme Corporation Pipeline Products By Therapy Area
    • Table 75: Genzyme Corporation Pipeline Products By Clinical Trials
    • Table 76: Genzyme Corporation Pipeline Products By News Summary
    • Table 77: Olympus Medical Systems Corp. Pipeline Products by Equipment Type
    • Table 78: Olympus Medical Systems Corp. Pipeline Products by Development Stage
    • Table 79: Olympus Medical Systems Corp. Pipeline Products by Therapy Area
    • Table 80: Olympus Medical Systems Corp. Pipeline Products by Clinical Trials
    • Table 81: Olympus Medical Systems Corp. Pipeline Products by News Summary
    • Table 82: ARKRAY, Inc. Pipeline Products by Equipment Type
    • Table 83: ARKRAY, Inc. Pipeline Products By Development Stage
    • Table 84: ARKRAY, Inc. Pipeline Products By Clinical Trials
    • Table 85: ARKRAY, Inc. Pipeline Products By News Summary
    • Table 86: Biomaster, Inc. Pipeline Products by Equipment Type
    • Table 87: Biomaster, Inc. Pipeline Products By Development Stage
    • Table 88: Biomaster, Inc. Pipeline Products By Therapy Area
    • Table 89: Eiken Chemical Co.,Ltd. Pipeline Products by Equipment Type
    • Table 90: Eiken Chemical Co.,Ltd. Pipeline Products By Development Stage
    • Table 91: Eiken Chemical Co.,Ltd. Pipeline Products By Therapy Area
    • Table 92: Sysmex Corporation Pipeline Products by Equipment Type
    • Table 93: Sysmex Corporation Pipeline Products By Development Stage
    • Table 94: Sysmex Corporation Pipeline Products By Therapy Area
    • Table 95: Sysmex Corporation Pipeline Products By News Summary
    • Table 96: Beckman Coulter To Acquire Olympus-DS From OLYMPUS
    • Table 97: Panasonic To Acquire Sanyo From Goldman Sachs, Daiwa Securities And Sumitomo Mitsui
    • Table 98: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Healthcare Expenditure in Japan, 2000 2005
    • Figure 2: Government and Private Healthcare Expenditure in Japan, 2005
    • Figure 3: Medical Device Classification in Japan, 2007
    • Figure 4: Approval Process for Controlled Medical Devices in Japan, 2007
    • Figure 5: Approval Process for Highly Controlled Medical Devices in Japan, 2007
    • Figure 6: Health Insurance Reimbursement Process in Japan, 2007
    • Figure 7: Distribution Structure for Medical Equipment in Japan, 2007
    • Figure 8: In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 9: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015
    • Figure 10: In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-2015
    • Figure 11: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 12: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 13: In Vitro Diagnostics, Japan, Company Share (%), 2007
    • Figure 14: Blood Test Reagents, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 15: Blood Test Reagents, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 16: Haematology Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 17: Haematology Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 18: Hemostasis Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 19: Hemostasis Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 20: Blood Test Reagents, Japan, Company Share (%), 2007
    • Figure 21: Clinical Chemistry Test Reagents, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 22: Clinical Chemistry Test Reagents, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 23: Clinical Chemistry Test Reagents, Japan, Company Share (%), 2007
    • Figure 24: Genetic Test Reagents, Japan, Revenue ($ mn), Historic, 2000-2008
    • Figure 25: Genetic Test Reagents, Japan, Revenue ($ mn), Forecast, 2008-2015
    • Figure 26: Genetic Test Reagents, Japan, Company Share (%), 2007
    • Figure 27: Immunochemistry Test Reagents, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 28: Immunochemistry Test Reagents, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 29: Disease Specific Markers, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 30: Disease Specific Markers, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 31: Disease Specific Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 32: Disease Specific Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 33: Drug Related Testing Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 34: Drug Related Testing Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 35: Hormone Related Testing Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 36: Hormone Related Testing Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 37: Immunochemistry Test Reagents, Japan, Company Share (%), 2007
    • Figure 38: Infectious Immunology Test Reagents, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 39: Infectious Immunology Test Reagents, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 40: Virology, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 41: Virology, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 42: Infectious Immunology Test Reagents, Japan, Company Share (%), 2007
    • Figure 43: Instruments, Japan, Revenue ($ mn), Historic, 2000-2008
    • Figure 44: Instruments, Japan, Revenue ($ mn), Forecast, 2008-2015
    • Figure 45: Instruments, Japan, Company Share (%), 2007
    • Figure 46: Microbiology Test Reagents, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 47: Microbiology Test Reagents, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 48: Bacteriology Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 49: Bacteriology Test Reagents, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 50: Microbiology Test Reagents, Japan, Company Share (%), 2007
    • Figure 51: Self Testing, Japan, Revenue ($ mn), Historic, 2000-2008
    • Figure 52: Self Testing, Japan, Revenue ($ mn), Forecast, 2008-2015
    • Figure 53: Self Testing, Japan, Company Share (%), 2007
    • Figure 54: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 55: Abbott Laboratories Value Chain Analysis
    • Figure 56: Beckman Coulter, Inc. Value Chain Analysis
    • Figure 57: Siemens Medical Solutions Value Chain Analysis
    • Figure 58: Abbott Laboratories Value Chain Analysis
    • Figure 59: Siemens Medical Solutions Value Chain Analysis
    • Figure 60: Becton, Dickinson and Company Value Chain Analysis
    • Figure 61: Gen-Probe Incorporated Value Chain Analysis
    • Figure 62: Biomerieux Sa Value Chain Analysis
    • Figure 63: Olympus Medical Systems Corp. Value Chain Analysis
    • Figure 64: KYOWA HAKKO KOGYO Co., Ltd. Value Chain Analysis
    • Figure 65: Nihon Kohden Corporation Value Chain Analysis
    • Figure 66: Global Markets Direct Methodology